In an immunocompromised adult who received the initial rabies post‑exposure prophylaxis dose on day 0, missed the day‑3 dose, and presents on day 7, how should the missed dose be managed and what is the appropriate subsequent vaccination schedule?

Management of Missed Rabies PEP Dose in Immunocompromised Patients

When an immunocompromised patient misses the day-3 dose but received day 0 and presents on day 7, administer the missed dose immediately upon presentation (on day 7) and continue the remaining doses at days 14 and 28, maintaining the 5-dose schedule required for immunocompromised individuals. 1

Core Principle: Resume Without Restarting

The fundamental approach to missed rabies vaccine doses is to continue the series from where it was interrupted—never restart the entire schedule. 2 Minor delays of individual doses do not compromise overall efficacy, and the series should simply resume with appropriate intervals from the last dose given. 2

Specific Algorithm for Your Scenario

Step 1: Immediate Action on Day 7

• Administer the missed day-3 dose immediately when the patient presents on day 7. 1
• This becomes the second dose in their series, even though it's delayed by 4 days. 1

Step 2: Complete the 5-Dose Immunocompromised Schedule

• Immunocompromised patients require all 5 doses on days 0,3,7,14, and 28—this is non-negotiable. 1
• After giving the delayed second dose on day 7, schedule the third dose for day 14 (7 days after the dose just given). 1
• Continue with doses on days 21 and 28 to complete the full 5-dose series. 1

Step 3: Verify HRIG Administration

• If HRIG was not given on day 0, it can still be administered up to and including day 7 of the PEP series. 1
• After day 7, HRIG must NOT be given, as vaccine-induced antibody response is presumed to have occurred. 2
• Administer 20 IU/kg body weight, infiltrating the full dose into and around wounds if anatomically feasible, with any remaining volume given IM at a site distant from vaccine administration. 1

Critical Pitfalls to Avoid

Do Not Reduce the Dose Count

• Never abbreviate to a 4-dose schedule in immunocompromised patients, even if doses are delayed. 1
• The 4-dose regimen (days 0,3,7,14) is only for immunocompetent individuals. 1, 3
• Immunosuppressed patients have impaired antibody responses and absolutely require the fifth dose on day 28. 1

Do Not Restart the Series

• Missing one dose does not invalidate previous doses—simply continue from where the patient left off. 2
• Restarting unnecessarily exposes the patient to additional vaccine doses without benefit and delays completion of adequate protection. 2

Maintain Proper Injection Sites

• Adults and older children: deltoid muscle only (mandatory). 1
• Never use the gluteal region, as this yields significantly lower neutralizing antibody titers and has been associated with prophylaxis failures. 1, 2

Special Considerations for Immunocompromised Patients

Higher Risk Profile

• Immunocompromised individuals mount weaker immune responses to rabies vaccine, necessitating the extended 5-dose schedule. 1
• Breakthrough infections, though rare, are more likely in patients with immunosuppression or those who deviate from core PEP practices. 4

Consider Serologic Testing

• While routine antibody testing is not recommended for healthy patients completing PEP, immunocompromised patients may benefit from titer checks 1-2 weeks after the final dose. 1
• A protective titer is ≥0.5 IU/mL by rapid fluorescent focus inhibition test (RFFIT). 1
• If titers are inadequate, additional booster doses may be warranted in consultation with infectious disease specialists. 1

Documentation and Follow-Up

• Document the reason for the missed dose and the revised schedule clearly in the medical record. 5
• Schedule all remaining appointments before the patient leaves to maximize compliance—missed doses are a significant barrier to adequate PEP completion. 5
• Patient compliance rates for completing rabies vaccine series can be as low as 69-82%, making proactive scheduling essential. 5

Reassurance About Efficacy

• Starting PEP as soon as possible after exposure is ideal, but delays of several days for individual doses do not eliminate protection when the series is completed appropriately. 2, 3
• The 5-dose regimen for immunocompromised patients, when administered correctly with proper wound care and HRIG, is highly effective at preventing rabies. 3, 4
• No patient in this scenario should be denied continuation of PEP—rabies is uniformly fatal once symptoms appear, making completion of the vaccine series absolutely critical. 6, 7